| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1100 | 2020 |
| Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition AJ Greaney, TN Starr, P Gilchuk, SJ Zost, E Binshtein, AN Loes, SK Hilton, ... Cell host & microbe 29 (1), 44-57. e9, 2021 | 1047 | 2021 |
| Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 MC Woodruff, RP Ramonell, DC Nguyen, KS Cashman, AS Saini, ... Nature immunology 21 (12), 1506-1516, 2020 | 626 | 2020 |
| p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho GA Wildenberg, MR Dohn, RH Carnahan, MA Davis, NA Lobdell, ... Cell 127 (5), 1027-1039, 2006 | 517 | 2006 |
| Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein SJ Zost, P Gilchuk, RE Chen, JB Case, JX Reidy, A Trivette, RS Nargi, ... Nature medicine 26 (9), 1422-1427, 2020 | 471 | 2020 |
| Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein N Suryadevara, S Shrihari, P Gilchuk, LA VanBlargan, E Binshtein, ... Cell 184 (9), 2316-2331. e15, 2021 | 356 | 2021 |
| Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ... Cell 184 (7), 1804-1820. e16, 2021 | 316 | 2021 |
| Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail J Dong, SJ Zost, AJ Greaney, TN Starr, AS Dingens, EC Chen, RE Chen, ... Nature microbiology 6 (10), 1233-1244, 2021 | 247 | 2021 |
| The PCH family protein, Cdc15p, recruits two F-actin nucleation pathways to coordinate cytokinetic actin ring formation in Schizosaccharomyces pombe RH Carnahan, KL Gould The Journal of cell biology 162 (5), 851-862, 2003 | 203 | 2003 |
| The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans YM Loo, PM McTamney, RH Arends, ME Abram, AA Aksyuk, S Diallo, ... Science translational medicine 14 (635), eabl8124, 2022 | 172 | 2022 |
| Vectors and gene targeting modules for tandem affinity purification in Schizosaccharomyces pombe JJ Tasto, RH Carnahan, W Hayes McDonald, KL Gould Yeast 18 (7), 657-662, 2001 | 169 | 2001 |
| Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly AG Bost, RH Carnahan, XT Lu, MR Denison Journal of virology 74 (7), 3379-3387, 2000 | 160 | 2000 |
| Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer AB Reynolds, RH Carnahan Seminars in cell & developmental biology 15 (6), 657-663, 2004 | 158 | 2004 |
| Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail J Dong, SJ Zost, AJ Greaney, TN Starr, AS Dingens, EC Chen, RE Chen, ... BioRxiv, 2021.01. 27.428529, 2021 | 127 | 2021 |
| Comparison of subgenomic and total RNA in SARS-CoV-2-challenged rhesus macaques G Dagotto, NB Mercado, DR Martinez, YJ Hou, JP Nkolola, RH Carnahan, ... Journal of virology 95 (8), 10.1128/jvi. 02370-20, 2021 | 103 | 2021 |
| ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes AL Smith, DB Friedman, H Yu, RH Carnahan, AB Reynolds PloS one 6 (1), e16206, 2011 | 92 | 2011 |
| The molecular evolution of the p120-catenin subfamily and its functional associations RH Carnahan, A Rokas, EA Gaucher, AB Reynolds PloS one 5 (12), e15747, 2010 | 92 | 2010 |
| Intramuscular delivery of replicon RNA encoding ZIKV-117 human monoclonal antibody protects against Zika virus infection JH Erasmus, J Archer, J Fuerte-Stone, AP Khandhar, E Voigt, B Granger, ... Molecular Therapy-Methods & Clinical Development 18, 402-414, 2020 | 81 | 2020 |
| Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization P Gilchuk, CD Murin, JC Milligan, RW Cross, CE Mire, PA Ilinykh, ... Immunity 52 (2), 388-403. e12, 2020 | 78 | 2020 |
| Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein P Gilchuk, N Kuzmina, PA Ilinykh, K Huang, BM Gunn, A Bryan, ... Immunity 49 (2), 363-374. e10, 2018 | 74 | 2018 |
James CroweVanderbilt University Medical CenterVerified email at vanderbilt.edu
